Literature DB >> 35641872

Oxidative Stress and Varicocele-Associated Male Infertility.

Terence Chun-Ting Lai1, Shubhadeep Roychoudhury2, Chak-Lam Cho3.   

Abstract

Despite being regarded as one of the most common causes of male subfertility, the pathophysiology of varicocele remains largely unknown. Recently, oxidative stress (OS) is proposed to be the mediator in how varicocele may negatively impact fertility. The imbalance of reactive oxygen species (ROS) and seminal antioxidants results in damage to sperm DNA and lipid membrane. There is evidence demonstrating higher OS level in men with varicocele which is also positively correlated with clinical grading of varicocele. Moreover, a number of studies have revealed the negative correlation between OS and conventional semen parameters. Furthermore, various interventions have shown their potential in alleviating OS in men with varicocele-associated infertility. Although direct evidence on improving pregnancy rate is not available at the moment, varicocelectomy has demonstrated promising results in relieving OS. Oral antioxidants represent another option with a favourable safety profile. The supplement can be used alone or as adjunct to varicocelectomy. However, most of the studies are hampered by heterogenous dose regime and high-level evidence is lacking.
© 2022. The Author(s), under exclusive license to Springer Nature Switzerland AG.

Entities:  

Keywords:  Antioxidant supplementation; Infertility; Pathophysiology; ROS; Semen parameters; Varicocele; Varicocelectomy

Mesh:

Substances:

Year:  2022        PMID: 35641872     DOI: 10.1007/978-3-030-89340-8_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  82 in total

Review 1.  Varicocele and male infertility: part I. Preface.

Authors:  S Benoff; B R Gilbert
Journal:  Hum Reprod Update       Date:  2001 Jan-Feb       Impact factor: 15.610

2.  Varicocele in subfertility; results of treatment.

Authors:  W S TULLOCH
Journal:  Br Med J       Date:  1955-08-06

3.  The impact of varicocelectomy on sperm parameters: a meta-analysis.

Authors:  Ingrid Schauer; Stephan Madersbacher; Romy Jost; Wilhelm Alexander Hübner; Martin Imhof
Journal:  J Urol       Date:  2012-03-14       Impact factor: 7.450

Review 4.  Insight into oxidative stress in varicocele-associated male infertility: part 1.

Authors:  Ashok Agarwal; Alaa Hamada; Sandro C Esteves
Journal:  Nat Rev Urol       Date:  2012-11-20       Impact factor: 14.432

5.  Does varicocele repair improve male infertility? An evidence-based perspective from a randomized, controlled trial.

Authors:  Taha A Abdel-Meguid; Ahmad Al-Sayyad; Abdulmalik Tayib; Hasan M Farsi
Journal:  Eur Urol       Date:  2010-12-21       Impact factor: 20.096

6.  Varicocele: a progressive or static lesion?

Authors:  M A Witt; L I Lipshultz
Journal:  Urology       Date:  1993-11       Impact factor: 2.649

7.  Seminal reactive oxygen species-antioxidant relationship in fertile males with and without varicocele.

Authors:  T Mostafa; T Anis; H Imam; A R El-Nashar; I A Osman
Journal:  Andrologia       Date:  2009-04       Impact factor: 2.775

Review 8.  Varicocele and male infertility.

Authors:  Christian Fuglesang S Jensen; Peter Østergren; James M Dupree; Dana A Ohl; Jens Sønksen; Mikkel Fode
Journal:  Nat Rev Urol       Date:  2017-07-04       Impact factor: 14.432

9.  A critical appraisal on the role of varicocele in male infertility.

Authors:  Ricardo Miyaoka; Sandro C Esteves
Journal:  Adv Urol       Date:  2011-11-28

10.  Adolescent varicocele: are somatometric parameters a cause?

Authors:  Kwonho Bae; Hong Seok Shin; Hyun-Jin Jung; Seok Hyun Kang; Byung Soo Jin; Jae Shin Park
Journal:  Korean J Urol       Date:  2014-08-08
View more
  1 in total

1.  Mailuoshutong pill for varicocele-associated male infertility-Phytochemical characterisation and multitarget mechanism.

Authors:  Dongfang Lv; Yun Ji; Qian Zhang; Zhuozhuo Shi; Tengfei Chen; Chao Zhang; Xiangyun Wang; Taotao Ren; Zhaowang Gao; Chongfu Zhong
Journal:  Front Pharmacol       Date:  2022-09-09       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.